Laird Norton Tyee Trust »

Immunome shares owned by Laird Norton Tyee Trust

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Laird Norton Tyee Trust from 13F filings

Historical chart of Laird Norton Tyee Trust investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Laird Norton Tyee Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Laird Norton Tyee Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $397k 19k 21.48

More positions owned by Laird Norton Tyee Trust

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Laird Norton Tyee Trust

Top funds holding Immunome

T. Rowe Price Investment Management
FMR
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
EcoR1 Capital
Geode Capital Management
Toronto-Dominion Bank
Readystate Asset Management
Sofinnova Ventures

View all funds holding Immunome